11723037

Source:http://linkedlifedata.com/resource/pubmed/id/11723037

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0332621, umls-concept:C0427611, umls-concept:C0522523, umls-concept:C1274040, umls-concept:C1522318, umls-concept:C1948041, umls-concept:C2587213, umls-concept:C2698651
pubmed:issue	22
pubmed:dateCreated	2001-11-27
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11723037-11181470
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Heparin
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1524-4539
pubmed:author	pubmed-author:BeyguiFF, pubmed-author:HelftGG, pubmed-author:MetzgerJ PJP, pubmed-author:le FeuvreCC
pubmed:issnType	Electronic
pubmed:day	27
pubmed:volume	104
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	E124
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:11723037-Angioplasty, Balloon, Coronary, pubmed-meshheading:11723037-Blood Coagulation, pubmed-meshheading:11723037-Data Interpretation, Statistical, pubmed-meshheading:11723037-Dose-Response Relationship, Drug, pubmed-meshheading:11723037-Endpoint Determination, pubmed-meshheading:11723037-Heparin, pubmed-meshheading:11723037-Humans, pubmed-meshheading:11723037-Randomized Controlled Trials as Topic, pubmed-meshheading:11723037-Risk, pubmed-meshheading:11723037-Whole Blood Coagulation Time
pubmed:year	2001
pubmed:articleTitle	Defining the optimal activated clotting times during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
pubmed:publicationType	Letter, Comment